Cardiff Oncology, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on June 10, 2021, specifically the Company's Annual Meeting of Stockholders. Cardiff Oncology, Inc. is a Delaware corporation trading on the Nasdaq Capital Market under the symbol CRDF.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance data.
Material Changes and Corporate Actions
The following matters were submitted to and voted upon by stockholders at the Annual Meeting:
- Director Elections: All eight (8) nominees were elected to the Board of Directors. A total of 23,963,305 shares were represented at the meeting.
- Independent Auditor: Stockholders ratified the appointment of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ended December 31, 2021.
- Equity Incentive Plan: Stockholders approved the adoption of the Company's 2021 Omnibus Equity Incentive Plan.
- Board Appointments: The Company announced the appointments of Mani Mohindru, Ph.D., and Renee P. Tannenbaum, Pharm.D., as independent members of the Board of Directors.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary on financial risks, or details on contingencies and unusual items. The document is limited to reporting the results of the stockholder vote and the associated board appointments.
Key Facts for Investor Verification
- Verify the full composition of the newly elected Board of Directors and the specific terms of their service.
- Review the details of the approved 2021 Omnibus Equity Incentive Plan to understand potential dilution or compensation structures.
- Confirm the engagement terms with the newly ratified auditor, BDO USA, LLP.
- Check the press release (Exhibit 99.1) for further details on the qualifications and roles of the newly appointed independent directors.